SutureTech earned FDA 510(k) clearance for its RapidFix device for soft tissue to bone fixation in orthopedic surgeries.
RapidFix is a suture-based internal fixation device and developed through eight years of surgeon collaboration, according to a Sept. 16 news release.
Following clearance, the company plans a limited market release of RapidFix in the fourth quarter.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.